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Domino reactions of ketones withmolecular oxygen in the presence of potassium hydroxide and potassium
t-butoxide aﬀord cyclic hydroperoxy acetals (3,5-dihydroxy-1,2-dioxanes). Mixed endoperoxides can also
be obtained in a three-component reaction of two ketones and oxygen.Introduction
Endoperoxides are important pharmacophores in a number of
natural and synthetic, biologically active compounds. Although
best known as potent antimalarials,1 cyclic peroxides also
exhibit a range of activities which encompasses anti-
tripanosomal,2 antifungal, antiviral and anticancer activity.3,4
Whereas tetraoxanes and trioxanes are important units of
synthetic bioactive peroxides, 1,2-dioxanes and dioxenes are the
most frequent constituents of naturally occuring endoperox-
ides. Therefore, synthetic chemists have invested considerable
eﬀorts in developing synthetic approaches to this class of
compounds.5
Results and discussion
During the course of a synthetic study of platensimycin, we
exposed methyl cyclopentyl ketone 1 to the enolization condi-
tions under a presumed argon atmosphere, aiming to perform
a Michael addition with the thermodynamic enolate. Surpris-
ingly, spectral data of the isolated compound did not match the
expected product, but indicated a dimeric structure with
a higher oxidation level. Detailed analysis of spectra indicated
the product structure 2 (Scheme 1). Stereochemical assignment
of the compound 2, as deduced from NOESY spectrum, was
conrmed by the results of X-ray diﬀraction structural analysis,
as represented in Fig. 1. As it was clear that the product arose
from the reaction of ketone enolate with molecular oxygen, thetry, University of Belgrade, Serbia
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hemistry 2015reaction was performed under an oxygen atmosphere, in order
to improve the yield; this time, surprisingly, endoperoxide 2was
not observed. The optimization of the reaction conditions
involved variations of the base, solvent, atmosphere and the
reaction temperature. We found that the highest yield of
endoperoxide 2 could be obtained when the reaction was per-
formed in THF, using a mixture of KOt-Bu and KOH as a base,
under an argon atmosphere where oxygen was present only in
low concentration; under these conditions, peroxide 2 could be
isolated in 48% yield as a crystalline, analytically pure
compound (Scheme 1, example 1). Cyclopent-3-enyl methyl
ketone 3 behaved similarly, aﬀording endoperoxide 4 in 43%
yield (Scheme 1, example 2).
In subsequent experiments, attempts were made to
accomplish cross-cyclotrimerization of two diﬀerent ketones
with oxygen. Indeed, the reaction of methyl cyclopentyl
ketone and acetone aﬀorded peroxide 6a in 64% yield (Table
1, entry 1). Several other ketones (5) were also submitted to
the cross-cyclotrimerization sequence with methyl cyclo-
pentyl ketone 1 and oxygen, to give the desired peroxide
products (mostly as crystalline compounds) in modest to fair
yields. In some cases the products (6) contained variable
amounts of the side product of homo-trimerization (2)
(entries 2, 3, 4 and 5).Scheme 1 Formation of 1,2-dioxanes 3 and 4 in the base-catalyzed
reactions of ketones 1 and 2 with oxygen.
RSC Adv., 2015, 5, 99577–99584 | 99577
Fig. 1 X-ray diﬀraction analysis of compound 2.
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
3 
N
ov
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
1/
18
/2
01
8 
8:
34
:4
8 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineHowever, the preponderance of the cross-products (6) is of
note, given the fact that ketones were used in equimolar
amounts. The results of these experiments are represented in
Table 1. All products were obtained as single stereoisomers,
with both hydroxy groups assuming axial positions (Fig. 2).Table 1 Cross-cyclotrimerizations of methyl cyclopentyl ketone with o
Entry Reactant (MeC(O)R1) Product
1
2
3
4
5
6
7
8
a Unless otherwise stated, the yields refer to the highest isolated yields of
NMR spectrum. c 6b : 2 ¼ 2.9 : 1. d 6c : 2 ¼ 17 : 1. e 6d : 2 ¼ 5 : 1. f 6e : 2
99578 | RSC Adv., 2015, 5, 99577–99584A literature search revealed that Barton and collaborators
encountered this reaction while inspecting more closely
autooxidation of isobutyrophenone.6 However, no subsequent
report on this reaction ensued, although “the phenomenon
certainly deserves further study”.7
The proposed reaction mechanism is represented in Scheme
2. It involves the oxidation of methyl cyclopentyl ketone enolate
7 with molecular oxygen to give hydroperoxide 8, which then
acts as the electrophile in subsequent aldol addition of enolate
9. Selectivity in cross-cyclotrimerization can be explained by the
well known propensity of methyl cyclopentyl ketone for the
formation of a thermodynamic enolate 7,8 which undergoes the
reaction with molecular oxygen.9 This reaction could proceed
either as a direct reaction of the enolate with triplet oxygen, or
via a cage radical pair mechanism; the intermediacy of freether ketones and molecular oxygen
T (C) Time (h) Yielda (%)
20 5 64
20 2 38b,c
40 3.5 43
56b,d
40 2 42b,e
40 5 39
59b,f
40 6 31
54b,g
40 6 67
40 4 28
recrystallized, analytically pure compounds. b Yield determined from 1H
¼ 6 : 1. g 6f : 2 ¼ 9 : 1.
This journal is © The Royal Society of Chemistry 2015
Fig. 2 Crystal structures of compounds 6c, 6e and 6f.
Scheme 2 Proposed reaction mechanism.
Table 2 Gibbs free energy changes for the formation of more
substituted enolates, calculated with two methods at BP86-D3/TZP
level of theory13
Ketone
DG (kcal mol1)
Method I Method II
1 3.92 3.99
3 4.08 4.48
5a 3.34 3.05
5b 3.72 3.14
5c 3.13 2.46
5d 3.81 3.54
5e 7.04 7.32
11 5.45 5.40
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View Article Onlineradical species can be ruled out, as the addition of BHT did not
inhibit the reaction. The hydroperoxide thus formed would
then act as the acceptor (probably activated by intramolecular
hydrogen bond) in the cross aldol addition. Surprisingly, this
mechanistic pathway was not corroborated with experimental
evidence. Hydroperoxide 8 (represented in Scheme 2 in the form
of the corresponding potassium salt) could be separately
prepared in 71% yield, when the reaction of methyl cyclopentyl
ketone with KOt-Bu was performed under an oxygen atmo-
sphere (this reaction is also unaﬀected by the presence of
BHT).10 However, a mixture of hydroperoxide 8 and methyl
cyclopentyl ketone 1 did not produce observable amounts of
endoperoxide 2 when exposed to the action of KOt-Bu.
To clarify the relationship between enolate stability and the
course of cross cyclotrimerization, and to explain the specic
reactivity of methyl cyclopent(en)yl ketone(s) 1 and 3, dispersion
corrected density functional theory calculations (DFT) were
performed. Free energy changes for the t-BuO mediated
formation of more substituted enolates in THF solution have
been calculated at BP86-D3/TZP level of theory (COSMO) withThis journal is © The Royal Society of Chemistry 2015two methods. (The rst one is based on direct calculation of
thermodynamic properties in THF within the COSMO model,11
while in the second, indirect method, the gas-phase free ener-
gies of reactants and products are corrected by solvation ener-
gies and energies due to the geometry relaxation of a molecule
in the solvent,12 see Computational details Section for details).
The results of both, direct and indirect method, are consistent,
and Gibbs free energies for the formation of more substituted
enolates, corresponding to all aliphatic ketones used in cross
trimerization reactions (1, 3, 5a–e) are listed in Table 2.14 It can
be seen that methyl cyclopentyl ketone 1 and methyl cyclo-
pentenyl ketone 3 have the most stable thermodynamic eno-
lates. This indicates that methyl cyclopentenyl ketone 3 should
also act as the acceptor in the cross cyclotrimerization reaction.
Indeed, when 3 was submitted to the cyclotrimerization
conditions in the presence of methyl isobutyl ketone 5c, endo-
peroxide 10 was obtained in 37% yield (Scheme 3, example 1).
With these results in hand, we searched for some other ketone
structures that would give rise to stable thermodynamic eno-
lates and hence be good partners for the cross cyclo-
trimerization. Calculations showed that indanyl methyl ketone
11 should be such a compound (Table 2), and indeed, its'
cyclotrimerization with acetone provided endoperoxide 12 in
77% yield (Scheme 3, example 2).
Some ketones did not participate in the cross-cyclo-
trimerization; these include progesterone, a-ionone, and 2-
acetylnorbornene, inter alia. Therefore, we searched for
a method to introduce the endoperoxide structural unit into
various structures, not directly obtainable by the reaction. To
this aim, cross-cyclotrimerisation was performed with acetyl-
styrene 13. Ozonolysis of the product 14 provided aldehyde 15,
which could be submitted to further synthetic transformations,
as examplied by the organometallic addition represented in
Scheme 4, which gave peroxy-triol 16. In this way, various
structural entities could be linked to the peroxide moiety, via
nucleophilic addition.RSC Adv., 2015, 5, 99577–99584 | 99579
Scheme 3 Reactions of ketones 3 and 11, as predicted by calculations.
Scheme 4 Linking the endoperoxide structural unit to other struc-
tures via organometallic addition.
RSC Advances Paper
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View Article OnlineConclusions
The new method for the synthesis of endoperoxides (1,2-diox-
anes) is described, which relies on the base-catalyzed cyclo-
trimerization of two ketones with molecular oxygen. The
domino reaction involves the oxidation of 1-cyclo-
pentylethanone with molecular oxygen, cross-aldol addition
and cyclization. The product of the reaction with acetylstyrene is
amenable to further synthetic transformations, which allows for
the linkage of the endoperoxide structural unit with other
molecules.Experimental
General experimental
All chromatographic separations were performed on silica, 10–
18, 60A, ICN Biomedicals. Standard techniques were used for
the purication of reagents and solvents. NMR spectra were
recorded on a Bruker Avance III 500. Chemical shis are
expressed in ppm (d) using tetramethylsilane as internal stan-
dard. IR spectra were recorded on a Nicolet 6700 FT instrument,
and are expressed in cm1. Mass spectra were obtained on
Agilent technologies 6210 TOF LC/MS instrument (LC: series
1200). Melting points were determined on an electrothermal
apparatus and are corrected. Microanalyses were performed
using the Vario EL III instrument CHNOS Elementar Analyzer,99580 | RSC Adv., 2015, 5, 99577–99584Elementar Analysensysteme GmbH, Hanau, Germany. Diﬀrac-
tion data were collected on an Oxford Diﬀraction KM4 four-
-circle goniometer equipped with Sapphire CCD detector.
General procedure for the synthesis of endoperoxides: 8-
cyclopentyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol (2).
KOt-Bu (55.2 mg; 0.493 mmol; 1.97 equiv.) and KOH (4.8 mg,
0.085 mmol, 0.34 equiv.) were added to a cold (0 C) solution of
1-cyclopentylethanone (28 mg; 0.25 mmol) in THF (0.5 mL),
with stirring, under an argon atmosphere. During the addition
of the base, the cork was opened for 10 s, so that the air could
enter into the reaction ask. The reacting solution should
occupy 14 of the ask volume (in this experiment a 2mL ask was
used). The reaction mixture was stirred for 1 h, when TLC
indicated the consumption of the starting material. The reac-
tion was quenched by the addition of water and 10% citric acid
to attain pH 4, followed by ethyl acetate extraction. The organic
extract was dried over MgSO4 anh., ltered and concentrated
under reduced pressure. Purication of the residue by column
chromatography (SiO2; eluent: petroleum-ether/ethyl acetate ¼
8/2) aﬀorded 15.5 mg (48%) of the title compound (2), as white
solid. Crystallization from petroleum-ether/ethyl acetate gave
white crystals, mp 111–112 C. 1H NMR (500 MHz, CDCl3) d 4.05
(d, J ¼ 1.0 Hz, 1H, OH), 3.61 (s, 1H, OH), 2.26–2.18 (m, 1H),
2.06–1.92 (m, 2H), 1.91–1.43 (m, 14H), 1.83 (d, J ¼ 14.1 Hz, 1H),
1.75 (dd, J ¼ 14.0 and 0.8 Hz, 1H), 1.18 (s, 3H). 13C NMR (125
MHz, CDCl3) d 103.2 (C), 96.3 (C), 71.0 (C), 47.5 (CH), 39.6 (CH2),
32.1 (CH2), 31.4 (CH2), 26.6 (CH2), 25.9 (CH2), 25.8 (CH2), 25.7
(CH2), 25.6 (CH2), 24.8 (CH2), 24.3 (CH3). IR (lm) nmax: 3456,
3367, 2953, 2868, 1730, 1665, 1451 1379, 1305. HRMS (ESI-TOF
high acc.) calcd for C14H24O4 (M + NH4
+): 274.2013, found:
274.2010. Microanalysis: calcd for C14H20O4: C 65.60; H 9.44%;
found: C 65.37; H 9.51.
8-(Cyclopent-3-enyl)-10-methyl-6,7-dioxaspiro[4.5]dec-2-ene-
8,10-diol (4). According to the procedure for the preparation of
compound 2, using 1-(cyclopent-3-enyl)ethanone (48.6 mg, 0.44
mmol), KOt-Bu (134 mg; 1.2 mmol; 2.7 equiv.) and KOH (12 mg,
0.2 mmol, 0.45 equiv.) in THF (1.2 mL) at 20 C for 2 h.
Purication of the crude material by column chromatography
(SiO2; eluent: petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 24
mg (43%) of the title compound (4), as white solid. Crystalli-
zation from petroleum-ether/ethyl acetate gave white crystals,
mp 68–70 C. 1H NMR (500 MHz, CDCl3) d 5.69–5.62 (m, 4H),
3.94 (d, J¼ 1.3 Hz, 1H, OH), 3.72 (s, 1H, OH), 3.05–2.97 (m, 1H),
2.85–2.78 (m, 1H), 2.50–2.31 (m, 6H), 2.21–2.12 (m, 1H), 1.85 (d,
J ¼ 14.1 Hz, 1H), 1.75 (dd, J ¼ 14.1 and 1.2 Hz, 1H), 1.16 (s, 3H).
13C NMR (125 MHz, CDCl3) d 129.5 (CH), 129.3 (CH), 128.1 (2 
CH), 103.3 (C), 94.9 (C), 70.8 (C), 45.1 (CH), 39.1 (CH2), 38.6
(CH2), 37.9 (CH2), 33.6 (CH2), 32.7 (CH2), 24.3 (CH3). IR (lm)
nmax: 3422, 3056, 2929, 2856, 1707, 1622, 1547, 1430, 1379, 1345.
HRMS (ESI-TOF high acc.) calcd for C14H20O4 (M + K
+):
291.0993, found: 291.0988. Microanalysis: calcd for C14H20O4: C
66.65; H 7.99%; found: C 66.28; H 8.04.
8,10-Dimethyl-6,7-dioxaspiro[4.5]decane-8,10-diol (6a).
According to the procedure for the preparation of compound 2,
using 1-cyclopentylethanone (20 mg; 0.179 mmol), propan-2-
one (10.35 mg; 0.179 mmol), KOt-Bu (80 mg; 0.714 mmol; 4
equiv.) and KOH (4.3 mg; 0.107 mmol; 0.6 equiv.) in THF 1 mLThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineat 20 C for 5 h. Purication of the residue by column chro-
matography (SiO2; eluent: petroleum-ether/ethyl acetate ¼ 8/2)
aﬀorded 23 mg (64%) of title compound (6a), as white solid, mp
98 C. 1H NMR (500 MHz, CDCl3) d 4.70 (s, 1H, OH), 3.50 (s, 1H,
OH), 2.27–2.19 (m, 1H), 1.98–1.83 (m, 3H), 1.82–1.72 (m, 2H),
1.68–1.45 (m, 4H), 1.34 (s, 3H), 1.18 (s, 3H).13C NMR (125 MHz,
CDCl3) d 100.3 (C), 96.1 (C), 71.3 (C), 42.1 (CH2), 32.0 (CH2), 31.3
(CH2), 26.0 (CH3), 25.7 (CH2), 24.7 (CH2), 24.1 (CH3). IR (lm)
nmax: 3421, 2960, 2872, 1446, 1378, 1323, 1214, 1170, 1080.
HRMS (ESI-TOF high acc.) calcd for C10H18O4 (M + Na)
+:
225.1097, found: 225.1094.
8-Isopropyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol (6b).
According to the procedure for the preparation of compound 2,
using 1-cyclopentylethanone (28 mg; 0.25 mmol), 4-methyl-
pentan-2-one (21 mg; 0.25 mmol), KOt-Bu (110.5 mg; 0.986
mmol; 3.94 equiv.) and KOH (9.5 mg; 0.17 mmol; 0.68 equiv.) in
THF (1 mL) at 20 C for 2 h. Purication of the crude material
by column chromatography (SiO2; eluent: petroleum-ether/ethyl
acetate ¼ 8/2) aﬀorded 36 mg of white solid, the mixture of the
title compound 6b and 8-cyclopentyl-10-methyl-6,7-dioxaspiro
[4.5]decane-8,10-diol (2) in 2.9 : 1 ratio, as determined from the
integrals of OH signals in the 1H NMR spectrum. This sample
contained a small amount of an unidentied impurity which
could not be separated by column chromatography. 1H NMR
(500 MHz, CDCl3) d 3.88 (d, J ¼ 1.3 Hz, 1H, OH), 3.56 (s, 1H,
OH), 2.26–2.16 (m, 1H), 2.03–1.92 (m, 1H), 1.91–1.43 (m, 7H),
1.79 (d, J ¼ 14.0 Hz, 1H), 1.72 (dd, J ¼ 14.0 and 1.2 Hz, 1H), 1.19
(s, 3H), 0.97 (d, J¼ 6.9 Hz, 3H), 0.96 (d, J¼ 6.9 Hz, 3H). 13C NMR
(125 MHz, CDCl3) d 103.3 (C), 96.3 (C), 71.0 (C), 37.7 (CH2), 36.3
(CH), 32.1 (CH2), 31.4 (CH2), 25.8 (CH2), 24.8 (CH2), 24.3 (CH3),
16.5 (CH3), 15.8 (CH3). IR (lm) nmax: 3365, 3443, 3404, 2960,
2872, 1730, 1659, 1453, 1382, 1327. HRMS (ESI-TOF high acc.)
calcd for C12H22O4 (M + NH4
+): 248.1856, found: 248.1848.
8-Isobutyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol (6c).
According to the procedure for the preparation of compound 2,
using 1-cyclopentylethanone (28 mg; 0.25 mmol), 4-methyl-
pentan-2-one (21 mg; 0.25 mmol; 1 equiv.), KOt-Bu (110.5 mg;
0.99 mmol; 3.94 equiv.) and KOH (9.5 mg; 0.17 mmol; 0.68
equiv.) in THF (1 mL) at 40 C for 3.5 h. Purication of the
crude material by column chromatography (SiO2; eluent:
petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 39 mg of white
solid, which is the mixture of the title compound (6c) and 8-
cyclopentyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol (2),
in a 17 : 1 ratio, as determined from the integrals of OH signals
in the 1H NMR spectrum. Crystallization from petroleum-ether/
ethyl acetate gave white crystals (43%), mp 64–65 C. 1H NMR
(500 MHz, CDCl3) d 4.19 (d, J ¼ 1.0 Hz, OH), 3.42 (s, 1H, OH),
2.26–2.18 (m, 1H), 1.99–1.72 (m, 4H), 1.84 (d, J ¼ 14.0 Hz, 1H),
1.75 (dd, J ¼ 13.9 and 1 Hz, 1H), 1.70–1.39 (m, 6H), 1.18 (s, 3H),
0.98 (d, J ¼ 9.1 Hz, 3H), 0.96 (d, J ¼ 9.1 Hz, 3H). 13C NMR (125
MHz, CDCl3) d 102.3 (C), 96.2 (C), 71.2 (C), 47.8 (CH2), 41.1
(CH2), 32.3 (CH2), 31.4 (CH2), 25.9 (CH2), 24.8 (CH2), 24.3 (CH3),
24.2 (CH3), 23.9 (CH3), 23.2 (CH). IR (lm) nmax: 3412, 2957,
2871, 1711, 1454, 1380, 1297. HRMS (ESI-TOF high acc.) calcd
for C15H26O4 (M + NH4
+): 288.2169, found: 288.2161.
10-Methyl-8-(4-methylpent-3-enyl)-6,7-dioxaspiro[4.5]decane-
8,10-diol (6d). According to the procedure for the preparation ofThis journal is © The Royal Society of Chemistry 2015compound 2, using 1-cyclopentylethanone (28 mg; 0.25 mmol; 1
equiv.), 6-methylhept-5-en-2-one (31.5 mg; 0.25 mmol; 1 equiv.),
KOt-Bu (110.5 mg; 0.986 mmol; 3.94 equiv.) and KOH (9.5 mg;
0.17 mmol; 0.68 equiv.) in THF (1 mL) at 40 C for 2 h. Puri-
cation of the crude material by column chromatography (SiO2;
eluent: petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 33 mg of
the pale yellow oil, which is the mixture of the title compound
(6d) and 8-cyclopentyl-10-methyl-6,7-dioxaspiro[4.5]decane-
8,10-diol (2) in a 5 : 1 ratio, as determined from the integrals of
OH signals in the 1H NMR spectrum. 1H NMR (500 MHz, CDCl3)
d 5.09 (t, J¼ 7.0 Hz, 1H), 4.43 (s, 1H, OH), 3.69 (s, 1H, OH), 2.28–
2.03 (m, 3H), 2.03–1.91 (m, 1H), 1.91–1.42 (m, 10H), 1.68 (s, 3H),
1.62 (s, 3H), 1.18 (s, 3H). 13C NMR (125 MHz, CDCl3) d 132.6 (C),
123.3 (CH), 101.7 (C), 96.4 (C), 71.0 (C), 40.6 (CH2), 38.9 (CH2),
32.1 (CH2), 31.4 (CH2), 25.8 (CH2), 25.6 (CH3), 24.8 (CH2), 24.1
(CH3), 21.2 (CH2), 17.6 (CH3). IR (lm) nmax: 3432, 3374, 2958,
2931, 2869, 1666, 1450, 1449, 1379. HRMS (ESI-TOF high acc.)
calcd for C15H26O4 (M + NH4
+): 288.2169, found: 288.2161.
8-Cyclopropyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol
(6e). According to the procedure for the preparation of
compound 2, using 1-cyclopentylethanone (46.7 mg; 0.417
mmol; 1 equiv.), 1-cyclopropylethanone (35 mg; 0.417 mmol; 1
equiv.), KOt-Bu (186.9 mg; 1.668 mmol; 4 equiv.) and KOH (16.1
mg; 0.287 mmol; 0.69 equiv.) in THF (1.6 mL) at 40 C for 5 h.
Purication of the crude material by column chromatography
(SiO2; eluent: petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 63.2
mg of the white solid, the mixture of the title compound (6e)
and 8-cyclopentyl-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-
diol (2) in a 6 : 1 ratio, as determined from the integrals of OH
signals in the 1H NMR spectrum. Crystallization from petro-
leum-ether/ethyl acetate gave white crystals (39%), mp 106–
107 C. 1H NMR (500 MHz, CDCl3) d 4.04 (s, 1H, OH), 3.42 (s,
1H, OH), 2.30–2.19 (m, 1H), 2.00–1.90 (m, 1H), 1.90–1.82 (m,
1H), 1.86 (s, 2H), 1.82–1.71 (m, 1H), 1.72–1.52 (m, 3H), 1.43–1.43
(m, 1H), 1.19 (s, 3H), 0.97 (tt, J ¼ 8.4 and 5.3 Hz, 1H), 0.66–0.58
(m, 1H), 0.55–0.38 (m, 3H). 13C NMR (125 MHz, CDCl3) d 100.5
(C), 96.3 (C), 71.3 (C), 41.5 (CH2), 32.1 (CH2), 31.3 (CH2), 25.7
(CH2), 24.7 (CH2), 24.2 (CH3), 18.1 (CH), 0.7 (CH2), 0.1 (CH2). IR
(lm) nmax: 3424, 3362, 2960, 2872, 1659, 1636, 1471, 1381, 1322.
HRMS (ESI-TOF high acc.) calcd for C12H20O4 (M + H
+):
229.1434, found: 229.1431. Microanalysis: calcd for C12H20O4: C
63.14; H 8.83%; found: C 62.93; H 8.82.
10-Methyl-8-phenyl-6,7-dioxaspiro[4.5]decane-8,10-diol (6f).
According to the procedure for the preparation of compound 2,
using 1-cyclopentylethanone (46.7 mg; 0.417 mmol; 1 equiv.), 1-
phenylethanone (50 mg; 0.417 mmol; 1 equiv.), KOt-Bu (186.9
mg; 1.668 mmol; 4 equiv.) and KOH (16.1 mg; 0.287 mmol; 0.69
equiv.) in THF (1.6 mL) at 40 C for 6 h. Purication of the
crude material by column chromatography (SiO2; eluent:
petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 66.5 mg of white
solid, the mixture of the title compound (6f) and 8-cyclopentyl-
10-methyl-6,7-dioxaspiro[4.5]decane-8,10-diol (2) in a 9 : 1 ratio,
as determined from the integrals of OH signals in the 1H NMR
spectrum. Crystallization from petroleum-ether/ethyl acetate
gave white crystals (31%), mp (dec.) 125 C. 1H NMR (500 MHz,
CDCl3) d 7.56–7.50 (m, 2H), 7.42–7.32 (m, 3H), 4.54 (s, 1H, OH),
3.60 (s, 1H, OH), 2.48–2.40 (m, 1H), 2.06 (s, 2H), 2.02 (dd, J ¼RSC Adv., 2015, 5, 99577–99584 | 99581
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View Article Online14.8 and 7.6 Hz, 1H), 1.99–1.91 (m, 1H), 1.89–1.78 (m, 1H), 1.77–
1.52 (m, 4H), 1.21 (s, 3H). 13C NMR (125 MHz, CDCl3) d 141.0
(C), 128.9 (CH), 128.4 (CH), 125.4 (CH), 101.1 (C), 96.5 (C), 71.3
(C), 43.7 (CH2), 32.4 (CH2), 31.5 (CH2), 25.9 (CH2), 24.9 (CH2),
24.1 (CH3). IR (lm) nmax: 3357, 3139, 2976, 2933, 2867, 1707,
1657, 1632, 1492, 1449, 1431, 1381. HRMS (ESI-TOF high acc.)
calcd for C15H20O4 (M + NH4
+): 282.1700, found: 282.1697.
Microanalysis: calcd for C12H20O4: C 68.16; H 7.63%; found: C
68.55; H 7.54.
8-(4-Bromophenyl)-10-methyl-6,7-dioxaspiro[4.5]decane-8,10-
diol (6g). According to the procedure for the preparation of
compound 2, using 1-cyclopentylethanone (37 mg; 0.33 mmol),
1-(4-bromophenyl)ethanone (102 mg; 0.512 mmol), KOt-Bu (154
mg; 1.38 mmol) and KOH (8.3 mg; 0.207 mmol; 0.6 equiv.) in
THF (2 mL) at 40 C for 5 h. Purication of the residue by
column chromatography (SiO2; eluent: petroleum-ether/ethyl
acetate ¼ 8/2) aﬀorded 76 mg (67%) of title compound (6g), as
a white solid, mp 143 C. 1H NMR (500 MHz, CDCl3) d 7.50–7.47
(m, 2H), 7.40–7.36 (m, 2H), 5.02 (s, 1H, OH), 3.44 (s, 1H, OH),
2.43–2.35 (m, 1H), 2.00 (s, 2H), 1.98–1.91 (m, 1H), 1.86–1.77 (m,
1H),1.75–1.59 (m, 4H), 1.58–1.51 (m, H), 1.20 (s, 3H).13C NMR
(125 MHz, CDCl3) d 141.0 (C), 131.8 (CH), 127.3 (CH), 123.3 (C),
101.3 (C), 96.5 (C), 71.9 (C), 43.7 (CH2), 32.7 (CH2), 31.8 (CH2),
26.1 (CH2), 25.0 (CH2), 24.4 (CH3). IR (lm) nmax: 3453, 3408,
3375, 2928, 2856, 1593, 1446, 1388, 1226, 1137, 1057. HRMS
(ESI-TOF high acc.) calcd for C15H19BrO4 (M + K)
+: 381.0098,
found: 381.0091.
10-Methyl-8-(pyridin-4-yl)-6,7-dioxaspiro[4.5]decane-8,10-diol
(6h). According to the procedure for the preparation of
compound 2, using 1-cyclopentylethanone (28 mg; 0.25 mmol; 1
equiv.), 1-(pyridin-4-yl)ethanone (30 mg; 0.25 mmol; 1 equiv.),
KOt-Bu (110.5 mg; 0.99 mmol; 3.94 equiv.) and KOH (9.5 mg;
0.17 mmol; 0.68 equiv.) in THF (1 mL) at 40 C for 4 h. Puri-
cation of the crude material by column chromatography (SiO2;
eluent: petroleum-ether/ethyl acetate ¼ 1/4) aﬀorded 18.4 mg
(28%) of the title compound (6h) as a pale yellow solid, mp
(dec.) 128–130 C. 1H NMR (500 MHz, CDCl3) d 8.43 (dd, J¼ 11.5
and 6.2 Hz), 7.40 (dd, J ¼ 4.7 and 1.4 Hz, 2H), 4.54–4.09 (s, 1H,
OH), 2.46–2.34 (m, 1H), 2.11–1.87 (m, 2H), 1.99 (d, J¼ 14.1, 1H),
1.91 (d, J ¼ 14.0 Hz, 1H), 1.87–1.77 (m, 1H), 1.77–1.51 (m, 4H),
1.21 (s, 3H). 13C NMR (125MHz, CDCl3) d 150.2 (C), 149.2 (2CH),
120.2 (2CH), 100.3 (C), 96.8 (C), 71.0 (C), 43.5 (CH2), 32.5 (CH2),
31.5 (CH2), 25.9 (CH2), 24.9 (CH2), 24.0 (CH3). IR (lm) nmax:
3331, 2962, 2870, 1702, 1671, 1606, 1454, 1412, 1379, 1326.
HRMS (ESI-TOF high acc.) calcd for C14H19O4 (M + H
+):
266.1387, found: 266.1386.
1-(1-Hydroperoxycyclopentyl)ethanone (8).10 KOt-Bu (531
mg; 4.74 mmol; 1.77 equiv.) was dissolved in a solvent mixture:
t-BuOH (4.3 mL) and DME (4.3 mL) under an argon atmosphere,
and the resulting yellow-orange solution was cooled to 30 C.
Aer that, oxygen was bubbled through the solution until the
reaction was complete. 1-Cyclopentylethanone (300 mg; 2.68
mmol; 1 equiv.) was added and the reaction mixture was stirred
for the next 75 minutes, when TLC (petroleum-ether/ethyl
acetate ¼ 4 : 1, PAA) indicated that nearly all of the substrate
was converted and the product was starting to decay. Ice-cold
sat. NaHCO3 (3 mL) was added, layers were separated, pH of the99582 | RSC Adv., 2015, 5, 99577–99584aqueous layer was adjusted to 3–4 using conc. H3PO4 (0.5 mL),
diluted with water and extracted with diethyl ether (2  10 mL).
The combined etheral extract was dried over anhydrous MgSO4,
ltered and concentrated under reduced pressure to aﬀord the
crude product, which was puried by column chromatography
(SiO2; eluent: petroleum-ether/ethyl acetate ¼ 6 : 1). Pure
hydroperoxyde 8 (275.8 mg, 71%) was isolated as a colorless
liquid. 1H NMR (500 MHz, CDCl3) d 9.51 (s, 1H, OOH), 2.33 (s,
3H), 2.03–1.85 (m, 4H), 1.83–1.64 (m, 4H). 13C NMR (125 MHz,
CDCl3) d 211.7 (C), 99.0 (C), 33.3 (CH2), 25.2 (CH3), 25.0 (CH2).
IR (lm) nmax: 3385, 2961, 2874, 1707, 1435, 1358. HRMS (ESI-
TOF high acc.) calcd for C7H12O3 (M + NH4
+): 162.1125, found:
162.1120.
8-Isobutyl-10-methyl-6,7-dioxaspiro[4.5]dec-2-ene-8,10-diol (10).
According to the procedure for the preparation of compound 2,
using 1-(cyclopent-3-enyl)ethanone 3 (10 mg; 0.091 mmol), 4-
methylpentan-2-one 5c (9.1 mg; 0.091 mmol; 1 equiv.), KOt-Bu
(30.6 mg; 0.272 mmol; 3 equiv.) and KOH (2.6 mg; 0.047 mmol;
0.5 equiv.) in THF (0.5 mL) at 30 C for 3 h. The yield of the
crude product 10, as determined from 1H NMR spectrum, was
37%. Purication of the residue by column chromatography
(SiO2; eluent: petroleum-ether/ethyl acetate ¼ 3/1) aﬀorded 5.3
mg (19%) of title compound 10, as a white solid, mp 54–56 C.
1H NMR (500 MHz, CDCl3) d 5.67–5.64 (m, 2H), 3.93 (d, J ¼ 1.4
Hz, 1H, OH), 3.70 (s, 1H, OH), 3.03–2.99 (m, 1H), 2.83–2.79 (m,
1H), 2.42–2.37 (m, 1H), 2.18–2.14 (m, 1H), 1.93–1.93 (m, 1H),
1.87 (d, J ¼ 14.0 Hz, 1H), 1.77 (dd, J ¼ 14.0 and 1.4 Hz, 1H), 1.52
(dd, J¼ 14.5 and 5.7 Hz, 1H), 1.45 (dd, J¼ 14, 5 and 7.2 Hz), 1.14
(s, 3H), 0.98 (d, J ¼ 8.7 Hz, 3H), 0.97 (d, J ¼ 8.7 Hz). 13C NMR
(125 MHz, CDCl3) d 128.2 (CH), 128.1 (CH), 102.4 (C), 94.8 (C),
70.8 (C), 48.0 (CH2), 40.2 (CH2), 39.2 (CH2), 38.6 (CH2), 24.3
(CH3), 23.9 (CH3), 23.2 (CH). IR (lm) nmax: 3402, 3059, 2955,
2871, 1460, 1429, 1190, 1034, 870. HRMS (ESI-TOF high acc.)
calcd for C13H22O4 (M + K
+): 281.1150, found: 281.1154.
4,6-Dimethyl-10,30-dihydrospiro[[1,2]dioxane-3,20-indene]-4,6-
diol (12). According to the procedure for the preparation of
compound 2, using 1-(2,3-dihydro-1H-inden-2-yl)ethanone 11
(40 mg; 0.25 mmol; 1 equiv.), propan-2-one (14.5 mg; 0.25
mmol; 1 equiv.), KOt-Bu (112 mg; 1 mmol; 4 equiv.) and KOH
(9.8 mg; 0.175 mmol; 0.7 equiv.) in THF (1 mL) at 20 C for 17
h. Purication of the crudematerial by column chromatography
(SiO2; eluent: petroleum ether/ethyl acetate ¼ 7/3) aﬀorded
45.2 mg of the title compound 12 as a white solid. Crystalliza-
tion from petroleum-ether/ethyl acetate gave white crystals
(64%), mp 136–137 C. 1H NMR (500 MHz, CDCl3) d 7.19–7.12
(m, 4H), 4.79 (s, 1H, OH), 4.14 (s, 1H, OH), 3.60 (d, J¼ 17.2, 1H),
3.44 (d, J¼ 18.2, 1H), 3.02 (d, J¼ 17.2, 1H), 2.79 (d, J¼ 18.2, 1H),
1.94 (d, J ¼ 14.2, 1H), 1.85 (d, J ¼ 14.1, 1H), 1.37 (s, 3H), 1.14 (s,
3H). 13C NMR (125 MHz, CDCl3) d 140.5 (C), 140.2 (C), 126.7
(CH), 126.6 (CH), 124.7 (CH), 124.5 (CH), 100.7 (C), 95.1 (C), 70.9
(C), 41.4 (CH2), 38.6 (CH2), 38.2 (CH2), 26.1 (CH3), 24.3 (CH3). IR
(ATR) nmax: 3412, 3024, 2934, 2851, 2867, 1710, 1484, 1459, 1424,
1378, 1322. HRMS (ESI-TOF high acc.) calcd for C14H18O4 (M +
K+): 289.0837, found: 289.0834. Microanalysis: calcd for
C14H18O4: C 67.18; H 7.25%; found: C 66.83; H 7.54.
10-Methyl-8-(4-vinylphenyl)-6,7-dioxaspiro[4.5]decane-8,10-
diol (14). According to the procedure for the preparation ofThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinecompound 2, using 1-cyclopentylethanone (70 mg, 0.62 mmol),
1-(4-vinylphenyl)ethanone (137 mg, 0.94 mmol), potassium tert-
butoxide (280 mg, 2.5 mmol) and potassium hydroxide (21 mg;
0.37 mmol; 0.59 equiv.) in THF (4 mL) at 40 C, 6 h. Puri-
cation of the residue by column chromatography (SiO2; eluent:
petroleum-ether/ethyl acetate ¼ 8/2) aﬀorded 93 mg (51%) of
title compound, as a colorless liquid. 1H NMR (500MHz, CDCl3)
d 7.48–7.45 (m, 2H), 7.41–7.38 (m, 2H), 6.70 (dd, J ¼ 17.6, J ¼
10.9, 1H), 5.76 (dd, J ¼ 17.6, J ¼ 0.8, 1H), 5.27 (dd, J ¼ 10.9, J ¼
0.8, 1H), 4.78 (s, 1H, OH), 3.70 (s, 1H, OH), 2.45–2.39 (m, 1H),
2.20–1.98 (m, 1H), 2.03 (s, 2H), 1.96–1.90 (m, 1H),1.84–1.78 (m,
1H), 1.72–1.62 (m, 3H), 1.58–1.52 (m, 1H), 1.19 (s, 3H). 13C NMR
(125 MHz, CDCl3) d 140.2 (C), 138.6 (C), 136.1 (CH), 126.1 (CH),
125.3 (CH), 114.6 (CH2), 101.3 (C), 96.6 (C), 71.3 (C), 43.5 (CH2),
32.3 (CH2), 31.3 (CH2), 25.8 (CH2), 24.6 (CH2), 23.9 (CH3). IR
(lm) nmax: 3406, 2964, 2871, 1608, 1432, 1379, 1307, 1229, 1138,
1055, 840, 737. HRMS (ESI-TOF high acc.) calcd for C17H22O4 (M
+ K+): 329.1150, found: 329.1145.
4-(8,10-Dihydroxy-10-methyl-6,7-dioxaspiro[4.5]decan-8-yl)-
benzaldehyde (15). Ozone was bubbled through a cold (78 C)
solution of 10-methyl-8-(4-vinylphenyl)-6,7-dioxaspiro[4.5]
decane-8,10-diol (9; 40 mg, 0.138 mmol) in dichloromethane
(10 mL). As soon as the blue color of dissolved ozone was
detected, argon was bubbled through the reaction mixture for
3–5 min and dimethylsulde (0.5 mL) was added. The reaction
mixture was stirred at room temperature for 6 h, volatiles were
removed under reduced pressure and the residue was puried
by column chromatography (petroleum ether/ethyl acetate ¼
8/2), to yield 20.2 mg (50%) of aldehyde 15, as a colorless oil.
1H NMR (500 MHz, CDCl3) d 10.01 (s, 1H), 7.88–7.86 (m, 2H),
7.71–7.68 (m, 2H), 5.48 (s, 1H, OH), 3.54 (s, 1H, OH), 2.46–2.40
(m, 1H), 2.03 (s, 2H), 2.02–1.92 (m, 2H),1.85–1.80 (m, 1H),
1.75–1.62 (m, 3H), 1.60–1.53 (m, 1H), 1.23 (s, 3H). 13C NMR
(125 MHz, CDCl3) d 192.1 (CH), 146.9 (C), 136.3 (C), 129.7 (CH),
125.6 (CH), 101.0 (C), 96.6 (C), 71.6 (C), 43.5 (CH2), 32.3 (CH2),
31.3 (CH2), 25.9 (CH2), 24.8 (CH2), 24.8 (CH3). IR (lm) nmax:
3388, 2964, 2870, 1702, 1453, 1383, 1214, 1169, 1056, 830.
HRMS (ESI-TOF high acc.) calcd for C16H20O5 (M + K
+):
331.0942, found: 331.0940.
8-(4-(Hydroxyl(phenyl)methyl)phenyl)-10-methyl-6,7-dioxas-
piro[4.5]decane-8,10-diol (16). A solution of phenyllithium (1.5
M in dibutyl ether; 0.233 mL; 0.35 mmol; 1.5 equiv.) was added
to a cold (78 C) solution of aldehyde 11 (25.5 mg, 0.087 mmol)
in dry THF (1 mL), under an argon atmosphere. Aer 1 h of
stirring, the reaction was quenched with saturated NaHCO3 and
the product was extracted with ethyl acetate. The organic extract
was dried over anhydrous MgSO4, ltered and evaporated to
dryness. The residue was puried by dry-ash chromatography
(petroleum-ether/ethyl acetate ¼ 9/1), to yield 21.1 mg (65%) of
8-(4-(hydroxyl(phenyl)methyl)phenyl)-10-methyl-6,7-dioxaspiro
[4.5]decane-8,10-diol (16), as a colorless oil. 1H NMR (500 MHz,
CDCl3) d 7.50–7.44 (m, 2H), 7.42–7.30 (m, 6H), 5.83 (s, 1H), 4.60
(s, 1H, OH), 3.56 (s, 1H, OH), 2.45–2.37 (m, 1H), 2.33 (broad s,
1H, OH), 2.02 (s, 2H), 2.01–1.87 (m, 2H), 1.86–1.77 (m, 1H),
1.72–1.61 (m, 3H), 1.57–1.51 (m, 1H), 1.19 (s, 3H). 13C NMR (125
MHz, CDCl3) d 144.4 (C), 143.5 (C), 140.1 (C), 128.5 (CH), 127.9
(CH), 126.5 (CH), 125.3 (CH), 101.2(C), 96.4 (C), 75.9 (CH), 71.2This journal is © The Royal Society of Chemistry 2015(C), 43.5 (CH2), 32.3 (CH2), 31.4 (CH2), 25.8 (CH2), 24.7 (CH2),
24.1 (CH3). IR (lm) nmax: 3364, 2926, 2857, 1599, 1452, 1380,
1230, 1168, 1021, 737. HRMS (ESI-TOF high acc.) calcd for
C22H26O5 (M + Na
+): 393.1673, found: 393.1677.Computational details
All the calculations have been carried out with the Amsterdam
Density Functional program package, ADF2013.01.15 An all
electron Triple-zeta Slater-type orbitals (STO) plus one polari-
zation function (TZP) basis set has been used for all atoms.
Solvent eﬀects in THF solution are described with the COSMO
model16 as implemented in ADF.17 Geometry optimizations of
all investigated molecules, both in the gas phase and in
solution, were performed using general gradient functional
consisting of Becke's exchange18 and Perdew's correlation19
with Grimme's third-generation dispersion energy correction20
and Becke–Johnson dumping,21 i.e. BP86-D3 functional, with
Becke's integration grid of good quality.22 Analytical harmonic
frequencies23 were calculated at the same level of theory, in
order to ascertain that all the optimized structures correspond
to the minima on the potential energy surface. In addition,
vibrational analysis have been used to evaluate zero point
eﬀects, entropic and thermal corrections to the Gibbs free
energy. Gibbs free energy changes for a reaction of a ketone
with tert-butoxide, forming corresponding enolate and tert-
butanol in THF solution, have been calculated with two
methods. The two methods are employed because accurate
description of reactions in solutions are still not at the same
high levels as those in the gas phase, and there are debates in
the literature concerning the free energy calculations with
implicit solvation methods.24 The rst method is direct
calculation of thermodynamic properties within the COSMO
model. COSMO model takes eﬀectively into account cavita-
tion, internal energy and entropy eﬀects of the solvent, and
therefore can yield an estimate of the Gibbs free energies.25
The second method is indirect, and is based on the thermo-
dynamic cycle for proton exchange reactions, commonly
employed for the calculations of pKa values.12 With the indirect
method, the gas-phase free energies of reactants and products
are corrected by solvation energies and energies due to the
geometry relaxation in the solvent. These corrections are
straightforwardly acquired from energy diﬀerences between
the gaseous and solvated states, since COSMO implementa-
tion in ADF reports the energies relative to the gas phase
fragments.17Acknowledgements
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